-
Poly (I:C) for Dose-Resolved Innate Immunity
2026-09-05
Poly (I:C), a synthetic double-stranded RNA analog, can convert innate immune stimulation into a structured dose-response experiment. This article connects TLR3 biology with recent dose-dependent antiviral findings and practical assay design.
-
Epinephrine Bitartrate: Adrenergic Research Guide
2026-09-04
Epinephrine Bitartrate is a non-selective adrenergic receptor agonist for receptor signaling, cell-function, cardiovascular disease research, and related translational studies. Its strongest quantitative benchmark is a canine comparison showing rapid plasma exposure after intranasal administration, but the result does not establish human dosing or clinical equivalence.
-
PRDX6–GPX4 Control of Ferroptosis
2026-09-04
Hu et al. identify PRDX6 as a dual regulator of ferroptosis resistance: it hydrolyzes peroxidized phospholipids and promotes GPX4 recruitment to damaged membranes through a C47-dependent disulfide interaction. Combining PRDX6 inhibition with ferroptosis inducers increases lipid peroxidation and suppresses tumor growth, although the findings require further validation across cancer types and treatment settings.
-
Multianimal MRI for Pancreatic Tumor Monitoring
2026-09-03
Kempinska et al. describe a four-chamber MRI workflow that images up to four KPC mice in one acquisition while preserving high-resolution anatomical assessment of pancreatic tumors. The protocol reduces imaging burden and supports enrollment, longitudinal monitoring, and proof-of-concept evaluation of gemcitabine treatment in a clinically relevant pancreatic ductal adenocarcinoma model.
-
Protease Inhibitor Cocktail for Phosphoproteomics
2026-09-03
Protease Inhibitor Cocktail EDTA-Free helps preserve signaling proteins and labile phosphoproteins during cell and tissue lysis. This article connects pre-analytical protease control with mechanistic interpretation of p53-mutant lymphoma studies and sensitive downstream assays.
-
Anagliptin: A Causal Map for Vascular Assays
2026-09-02
Anagliptin (SK-0403) is more than a DPP-4 inhibitor in vascular research. This guide translates rabbit aortic-ring evidence into a practical framework for separating Kv channel modulation, SERCA pump regulation, and incretin-linked hypotheses.
-
Pioglitazone PPARγ Agonist Research Workflows
2026-09-02
Translate selective PPARγ activation into practical macrophage, beta-cell, metabolic, and neuroinflammation assays. This guide combines formulation controls, DSS-model insights, quantitative readouts, and troubleshooting strategies for more reproducible Pioglitazone research.
-
Linarin, Cyclin A2, and NSCLC Cell-Cycle Arrest
2026-09-01
A 2026 study identifies the Herba Patriniae component linarin as an inhibitor of NSCLC cell growth that promotes G0/G1 arrest, senescence, and apoptosis alongside reduced CCNA2, CCNB1, and CHEK1 expression. By combining network pharmacology with complementary cell-based assays in p53-wild-type and p53-null models, the work provides a mechanistic framework for studying linarin-associated cell-cycle disruption while highlighting the need for in vivo validation.
-
AR Dimer-Interface Antagonists Against CRPC Resistance
2026-09-01
The reference study reports benzo[b]oxepine-4-carboxamide derivatives that target the androgen receptor dimer interface pocket rather than its conventional ligand-binding pocket. Optimization produced Y5, a dual-action antagonist that disrupts AR dimerization, promotes AR degradation, and suppresses drug-resistant prostate cancer models after oral dosing.
-
GSH-Responsive MOF Nanoparticles for Melanoma Therapy
2026-08-31
Hao et al. engineered ICG-MOF-SS-AUNP12, a glutathione-responsive metal–organic framework nanoparticle that combines near-infrared photothermal therapy with PD-1/PD-L1 checkpoint inhibition. The study shows how stimulus-responsive release and immune activation can address the limited ability of single-modality photothermal therapy to control melanoma progression, recurrence, and immune escape.
-
Metal-Free Carbon Nanozymes for ALP Detection
2026-08-31
The reference study develops a metal-free carbon-dot nanozyme assay in which alkaline phosphatase hydrolysis of pyrophosphate relieves catalytic inhibition and generates a colorimetric turn-on signal. Its kinetic analysis identifies pyrophosphate as a noncompetitive inhibitor binding at a site distinct from the principal catalytic region, enabling sensitive ALP activity measurement with reduced risk of metal-ion interference.
-
nor-Binaltorphimine dihydrochloride: Circuit Assays
2026-08-30
Explore how nor-Binaltorphimine dihydrochloride can sharpen κ-opioid receptor antagonist assays by separating receptor pharmacology from brain-to-spinal circuit effects. This guide translates a 2024 mechanistic study into practical design, handling, and interpretation decisions for opioid receptor signaling research.
-
10 mM dNTP Mixture: Reliable DNA Synthesis
2026-08-29
Learn how SKU K1041, a defined 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture, can standardize PCR, qPCR, sequencing, and DNA synthesis steps associated with cell-based viability and cytotoxicity studies. The article separates direct cell-assay biology from downstream nucleic-acid workflow variables and provides practical handling, interpretation, and vendor-selection guidance.
-
Itraconazole for Candida Biofilm Research
2026-08-28
Itraconazole combines triazole antifungal activity with CYP3A4, hedgehog, and angiogenesis-related research utility. This guide translates PP2A–autophagy findings in Candida albicans biofilms into practical assay designs, concentration planning, and troubleshooting workflows.
-
Morning Training Improves Endurance Adaptation in Mice
2026-08-28
Hesketh et al. show that endurance-training time influences the magnitude and efficiency of adaptation in female mice, not merely the time at which performance is tested. Early-active-phase training produced a stronger improvement and distinct skeletal-muscle adaptations despite lower absolute workloads, providing a framework for circadian exercise studies and metabolic phenotyping.